Drug Pricing
Drug Pricing
What to Know in Washington: When Drugs Make News, Trump Reacts
Staffers at the Department of Health and Human Services have gotten used to a pattern: President Donald Trump sees a news report on spikes in prescription-drug list prices, Secretary Alex Azar is called to a meeting in the Oval Office, and a policy in the discussion stage gets accelerated and ...
Commentary
Let’s Let Market Forces Lower Drug Prices
The Trump Administration on July 31 announced steps that could lead to the importation of prescription drugs from Canada, where prices are lower. This strategy is favored by President Trump but has long been opposed by many Republicans. Health and Human Services Secretary Alex Azar said that the policy would enable Americans ...
Commentary
Louisiana Tries Hard, But Federal Obstacles Cause Hepatitis C Plan To Fall Short
A state and a biopharmaceutical company agreed recently on a new way to pay for treating patients with Hepatitis C, the most deadly infectious disease in America. At a time when politicians and drug companies are squabbling over drug prices, the deal between Louisiana and Asegua, a subsidiary of Gilead Sciences, ...
Commentary
Trump’s Drug Importation Policy Is Folly, Just Ask Canadians
The Trump Administration’s Department of Health and Human Services (HHS) has officially proposed legalizing the importation of drugs from Canada (e.g. the Safe Importation Action Plan). Canadians’ reactions provide an important perspective demonstrating why drug importation will harm the U.S. Despite assurances from Prime Minister Justin Trudeau, Canadians are worried ...
Commentary
PRI’s Henry Miller in the LA Times: A smarter way to curb drug prices through imports
A smarter way to curb drug prices through imports By Henry I. Miller, M.S., M.D. and John J. Cohrssen The Trump administration last week announced steps that could lead to the importation of prescription drugs from Canada, where prices are lower. It is a goal supported by President Trump, but long ...
Commentary
Sally Pipes: Bernie Sanders offers wrong solution to cut drug prices
Sen. Bernie Sanders, I-Vt., again defended his “Medicare-for all” plan Sunday, as he headed from Detroit to the nearby Canadian city of Windsor with a group of diabetics to dramatize the lower cost of insulin in Canada. Sanders is bound to mention his Canadian trip when he debates nine other presidential contenders ...
Commentary
Wayne Winegarden in Forbes: Inflation Caps Are Price Controls By Another Name
From the time we were toddlers, it has always been tempting to bang the square peg into the round hole. After all, there is always that one square peg that seems like it should just about fit into that round hole, and it would feel so satisfying if it did. ...
Commentary
Trump Scraps A Reform That Would Have Saved Patients Billions
This week, the Trump administration axed a proposal that would have saved American patients billions of dollars by shedding light on the complex drug supply chain. If enacted, the rule would have required insurers to share discounts they negotiate with drug companies directly with patients. The proposed rule would have changed the ...
Commentary
Flawed WHO Study Could Jeopardize Patients’ Access to Cancer Medicines
Determining whether the prices for medicines are appropriate or not is critically important, which is why studies that attempt to answer this question must stand up to scrutiny. Studies that undervalue medicines jeopardize the development of future cures, while studies that overvalue medicines justify the imposition of excessive health care ...
Commentary
We Need Reciprocity Of Drug Approvals To Address Critical Drug Shortages
By Henry I. Miller and John J. Cohrssen Published in Issues and Insights We hear a lot about rising drug prices, but largely ignored is a far more acute and worrisome problem: widespread shortages of critical medications, many of which are essential in medical practice. University of Chicago researchers last ...
What to Know in Washington: When Drugs Make News, Trump Reacts
Staffers at the Department of Health and Human Services have gotten used to a pattern: President Donald Trump sees a news report on spikes in prescription-drug list prices, Secretary Alex Azar is called to a meeting in the Oval Office, and a policy in the discussion stage gets accelerated and ...
Let’s Let Market Forces Lower Drug Prices
The Trump Administration on July 31 announced steps that could lead to the importation of prescription drugs from Canada, where prices are lower. This strategy is favored by President Trump but has long been opposed by many Republicans. Health and Human Services Secretary Alex Azar said that the policy would enable Americans ...
Louisiana Tries Hard, But Federal Obstacles Cause Hepatitis C Plan To Fall Short
A state and a biopharmaceutical company agreed recently on a new way to pay for treating patients with Hepatitis C, the most deadly infectious disease in America. At a time when politicians and drug companies are squabbling over drug prices, the deal between Louisiana and Asegua, a subsidiary of Gilead Sciences, ...
Trump’s Drug Importation Policy Is Folly, Just Ask Canadians
The Trump Administration’s Department of Health and Human Services (HHS) has officially proposed legalizing the importation of drugs from Canada (e.g. the Safe Importation Action Plan). Canadians’ reactions provide an important perspective demonstrating why drug importation will harm the U.S. Despite assurances from Prime Minister Justin Trudeau, Canadians are worried ...
PRI’s Henry Miller in the LA Times: A smarter way to curb drug prices through imports
A smarter way to curb drug prices through imports By Henry I. Miller, M.S., M.D. and John J. Cohrssen The Trump administration last week announced steps that could lead to the importation of prescription drugs from Canada, where prices are lower. It is a goal supported by President Trump, but long ...
Sally Pipes: Bernie Sanders offers wrong solution to cut drug prices
Sen. Bernie Sanders, I-Vt., again defended his “Medicare-for all” plan Sunday, as he headed from Detroit to the nearby Canadian city of Windsor with a group of diabetics to dramatize the lower cost of insulin in Canada. Sanders is bound to mention his Canadian trip when he debates nine other presidential contenders ...
Wayne Winegarden in Forbes: Inflation Caps Are Price Controls By Another Name
From the time we were toddlers, it has always been tempting to bang the square peg into the round hole. After all, there is always that one square peg that seems like it should just about fit into that round hole, and it would feel so satisfying if it did. ...
Trump Scraps A Reform That Would Have Saved Patients Billions
This week, the Trump administration axed a proposal that would have saved American patients billions of dollars by shedding light on the complex drug supply chain. If enacted, the rule would have required insurers to share discounts they negotiate with drug companies directly with patients. The proposed rule would have changed the ...
Flawed WHO Study Could Jeopardize Patients’ Access to Cancer Medicines
Determining whether the prices for medicines are appropriate or not is critically important, which is why studies that attempt to answer this question must stand up to scrutiny. Studies that undervalue medicines jeopardize the development of future cures, while studies that overvalue medicines justify the imposition of excessive health care ...
We Need Reciprocity Of Drug Approvals To Address Critical Drug Shortages
By Henry I. Miller and John J. Cohrssen Published in Issues and Insights We hear a lot about rising drug prices, but largely ignored is a far more acute and worrisome problem: widespread shortages of critical medications, many of which are essential in medical practice. University of Chicago researchers last ...
